During the COVID-19 health emergency, two strategies for detecting coronavirus infections were commonly adopted around the world. Part of Nature Outlook: Medical diagnostics Initially, in countries ...

AMES, Iowa – A machine that holds more than 5,000 samples on a plate no wider than a couple of postage stamps is among the innovations that could vastly enhance molecular diagnostic testing capacity ...

Molecular diagnostics are well-established in clinical medicine. Nonetheless, the markets for these tests remain one of the most attractive growth opportunities in the in vitro diagnostics industry.

Effective strategies are needed to facilitate the prompt diagnosis and treatment of tuberculosis in countries with a high burden of the disease. We conducted a cluster-randomized trial in which ...

An expert discusses the evolution of ROS1 testing in non-small cell lung cancer, highlighting the shift from FISH-based methods to comprehensive next-generation sequencing of both tissue and plasma, ...

Trends in Lung Cancer Incidence and Mortality (1990-2019) in the United States: A Comprehensive Analysis of Gender and State-Level Disparities A total of 7,413 tumor specimens were tested. The ...

We reviewed electronic medical records of patients with newly diagnosed, untreated metastatic NSCLC from December 2018 to August 2021 and determined the number of days from pathologic diagnosis to NGS ...

The COVID-19 pandemic continues to rage, with more than five million deaths worldwide. The urgent, global nature of the pandemic has led to great innovation with novel vaccines and diagnostics, ...

Please provide your email address to receive an email when new articles are posted on . Patients receiving a tyrosine kinase inhibitor after stage IV NSCLC diagnosis experienced extended OS. Receiving ...

In a major step towards strengthening cancer care services in the region, Government Medical College (GMC) Jammu has launched a state-of-the-art advanced molecular testing facility for cancer patients ...

Current guidelines recommend comprehensive molecular genotyping for newly diagnosed patients with metastatic non-squamous non-small cell lung cancer (NSCLC). A study presented at the American Society ...